For temporary relief of nervousness, anxiety, mood swings, joint pains, weakness, drowsiness, itching and lethargy. Not evaluated by the FDA, homeopathic product.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Serotonin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Serotonin. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Serotonin. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Serotonin. |
| Hydrocodone | Serotonin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Serotonin. |
| Magnesium sulfate | The therapeutic efficacy of Serotonin can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Serotonin may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Serotonin may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Serotonin. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Serotonin. |
| Orphenadrine | Serotonin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Serotonin may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Serotonin. |
| Pramipexole | Serotonin may increase the sedative activities of Pramipexole. |
| Ropinirole | Serotonin may increase the sedative activities of Ropinirole. |
| Rotigotine | Serotonin may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Serotonin. |
| Sodium oxybate | Serotonin may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Serotonin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Serotonin. |
| Thalidomide | Serotonin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Serotonin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Serotonin. |
| Linezolid | The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Serotonin. |
| Dicoumarol | The risk or severity of adverse effects can be increased when Serotonin is combined with Dicoumarol. |
| Phenindione | The risk or severity of adverse effects can be increased when Serotonin is combined with Phenindione. |
| Warfarin | The risk or severity of adverse effects can be increased when Serotonin is combined with Warfarin. |
| Phenprocoumon | The risk or severity of adverse effects can be increased when Serotonin is combined with Phenprocoumon. |
| Acenocoumarol | The risk or severity of adverse effects can be increased when Serotonin is combined with Acenocoumarol. |
| 4-hydroxycoumarin | The risk or severity of adverse effects can be increased when Serotonin is combined with 4-hydroxycoumarin. |
| Coumarin | The risk or severity of adverse effects can be increased when Serotonin is combined with Coumarin. |
| (R)-warfarin | The risk or severity of adverse effects can be increased when Serotonin is combined with (R)-warfarin. |
| Ethyl biscoumacetate | The risk or severity of adverse effects can be increased when Serotonin is combined with Ethyl biscoumacetate. |
| Fluindione | The risk or severity of adverse effects can be increased when Serotonin is combined with Fluindione. |
| Clorindione | The risk or severity of adverse effects can be increased when Serotonin is combined with Clorindione. |
| Diphenadione | The risk or severity of adverse effects can be increased when Serotonin is combined with Diphenadione. |
| Tioclomarol | The risk or severity of adverse effects can be increased when Serotonin is combined with Tioclomarol. |
| (S)-Warfarin | The risk or severity of adverse effects can be increased when Serotonin is combined with (S)-Warfarin. |
| Mirtazapine | Serotonin may increase the serotonergic activities of Mirtazapine. |
| Ethanol | Serotonin may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Serotonin may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Serotonin. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Serotonin is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Serotonin is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Serotonin is combined with Duloxetine. |
| Paroxetine | The risk or severity of adverse effects can be increased when Serotonin is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Serotonin is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Serotonin is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Serotonin is combined with Nefazodone. |
| Zimelidine | The risk or severity of adverse effects can be increased when Serotonin is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Serotonin is combined with Dapoxetine. |
| Milnacipran | The risk or severity of adverse effects can be increased when Serotonin is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Serotonin. |
| Seproxetine | The risk or severity of adverse effects can be increased when Serotonin is combined with Seproxetine. |
| Levomilnacipran | The risk or severity of serotonin syndrome can be increased when Serotonin is combined with Levomilnacipran. |
| Indalpine | The risk or severity of adverse effects can be increased when Serotonin is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Serotonin is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Serotonin is combined with Alaproclate. |
| Methylene blue | Serotonin may increase the serotonergic activities of Methylene blue. |
| Zopiclone | The risk or severity of adverse effects can be increased when Serotonin is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Serotonin. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Serotonin. |
| Tryptophan | The risk or severity of CNS depression can be increased when Tryptophan is combined with Serotonin. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Serotonin. |
| Lorazepam | The risk or severity of CNS depression can be increased when Lorazepam is combined with Serotonin. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Serotonin. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Serotonin. |
| Reserpine | The risk or severity of CNS depression can be increased when Reserpine is combined with Serotonin. |
| Eletriptan | The risk or severity of CNS depression can be increased when Eletriptan is combined with Serotonin. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Serotonin. |
| Temazepam | The risk or severity of CNS depression can be increased when Temazepam is combined with Serotonin. |
| Reboxetine | The risk or severity of CNS depression can be increased when Reboxetine is combined with Serotonin. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Serotonin. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Serotonin. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Serotonin. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Serotonin. |
| Phenytoin | The risk or severity of CNS depression can be increased when Phenytoin is combined with Serotonin. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Serotonin. |
| Clemastine | The risk or severity of CNS depression can be increased when Clemastine is combined with Serotonin. |
| Venlafaxine | The risk or severity of serotonin syndrome can be increased when Serotonin is combined with Venlafaxine. |
| Etomidate | The risk or severity of CNS depression can be increased when Etomidate is combined with Serotonin. |
| Morphine | The risk or severity of CNS depression can be increased when Morphine is combined with Serotonin. |
| Talbutal | The risk or severity of CNS depression can be increased when Talbutal is combined with Serotonin. |
| Pentobarbital | The risk or severity of CNS depression can be increased when Pentobarbital is combined with Serotonin. |
| Valproic acid | The risk or severity of CNS depression can be increased when Valproic acid is combined with Serotonin. |
| Zolmitriptan | The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Serotonin. |
| Codeine | The risk or severity of CNS depression can be increased when Codeine is combined with Serotonin. |
| Dihydroergotamine | The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Serotonin. |
| Amitriptyline | The risk or severity of CNS depression can be increased when Amitriptyline is combined with Serotonin. |
| Tolcapone | The risk or severity of CNS depression can be increased when Tolcapone is combined with Serotonin. |
| Hydromorphone | The risk or severity of CNS depression can be increased when Hydromorphone is combined with Serotonin. |
| Olanzapine | The risk or severity of CNS depression can be increased when Olanzapine is combined with Serotonin. |
| Cetirizine | The risk or severity of CNS depression can be increased when Cetirizine is combined with Serotonin. |
| Protriptyline | The risk or severity of CNS depression can be increased when Protriptyline is combined with Serotonin. |
| Trimethadione | The risk or severity of CNS depression can be increased when Trimethadione is combined with Serotonin. |
| Clobazam | The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Serotonin. |
| Chlorzoxazone | The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Serotonin. |
| Clozapine | The risk or severity of CNS depression can be increased when Clozapine is combined with Serotonin. |
| Meprobamate | The risk or severity of CNS depression can be increased when Meprobamate is combined with Serotonin. |